On  April 16, 2015, Governor Butch Otter of Idaho issued an executive order authorizing the Department of Health and Welfare to implement an FDA-approved expanded access program for treatment-resistant epilepsy in children.

He vetoed a bill that would have allowed a non-pharmacy grade of cannabidiol oil (CBD) to be purchased through an uncontrolled system from questionable sources. Instead, the governor decided upon a plan allowing children with intractable epilepsy to access Epidiolex, a pure, pharmaceutical-grade of CBD, through an FDA-approved clinical trial. Continue reading Governor of Idaho Allows CBD Trial Medicine →